Thiol Disulfide Balance in Cervix Cancer

CompletedOBSERVATIONAL
Enrollment

123

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

January 20, 2020

Study Completion Date

February 4, 2020

Conditions
Cervix CancerOxidative Stress
Interventions
DIAGNOSTIC_TEST

Disulphide(μmol/L)

Aforementioned oxidative stress markers will be measured via Cobas c501(Roche Diagnostics, Indianapolis, IN, USA) used with spectrophotometry

DIAGNOSTIC_TEST

Total Oxidant Capacity(μmolH2O2Equiv/L)

Aforementioned oxidative stress markers will be measured via Cobas c501(Roche Diagnostics, Indianapolis, IN, USA) used with spectrophotometry

DIAGNOSTIC_TEST

Ischemia Modified Albumin(IU/mL)

The serum Ischemia Modified Albumin concentrations were measured as described by Bar-Or et al. (Bar-Or et al. 2000).

Trial Locations (1)

48000

Mugla Sıtkı Kocman University Faculty of Medicine, Muğla

All Listed Sponsors
lead

Muğla Sıtkı Koçman University

OTHER

NCT04258553 - Thiol Disulfide Balance in Cervix Cancer | Biotech Hunter | Biotech Hunter